Zhao Ding
Fortuna: 442 M $ al 31/05/2026
Fortuna: 442 M $ al 31/05/2026
Zhao Ding is the founder of Sichuan Huiyu Pharmaceutical Co., Ltd., founded in 2010, and holds the titles of Chairman & General Manager since 2018.
Dr. Ding worked as a Non-Executive Director at TYK Medicines, Inc. from 2024 to 2025.
Dr. Ding earned a doctorate from the University of Cambridge.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/09/2025 | 118.489.207 ( 89,45 % ) | 310 M $ | 31/05/2026 | |
| 30/09/2025 | 50.329.607 ( 11,88 % ) | 132 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SICHUAN HUIYU PHARMACEUTICAL CO., LTD. | Director Ejecutivo | 12/10/2010 |
| Empresas | Cargo | Fin |
|---|---|---|
| TYK MEDICINES, INC | Director/Miembro de la Junta | 27/03/2025 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sichuan Huiyu Pharmaceutical Co., Ltd.
Sichuan Huiyu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
TYK Medicines, Inc.
TYK Medicines, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of therapies for cancer treatment | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.